Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes - Ramin-Mangata, Stéphane; Wargny, Matthieu; Pichelin, Matthieu; Le May, Cédric; Thédrez, Aurélie; Blanchard, Valentin; Nativel, Brice; Santos, Raul D.; Benseñor, Isabela M.; Lotufo, Paulo A.; Lambert, Gilles; Cariou, Bertrand (Atherosclerosis, 2020)
Keywords: Biomarkers - blood; Brazil - epidemiology; Cardiology and cardiovascular system; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - epidemiology; Disease Progression; Endocrinology and metabolism; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Human health and pathology; Humans; Hépatology and Gastroenterology; Incidence; Life Sciences; Male; Middle Aged; New onset diabetes; PCSK9; PCSK9 inhibition; Proprotein Convertase 9 - blood; Prospective Studies; Risk Factors; Time Factors; Tissues and Organs; Type 2 diabetes; Brazil; Type 2 diabetes; PCSK9; PCSK9 inhibition; New onset diabetes; new onset diabetes; type 2 diabetes